Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.050
-0.030 (-2.78%)
At close: Aug 1, 2025, 4:00 PM
1.040
-0.010 (-0.95%)
After-hours: Aug 1, 2025, 4:00 PM EDT
Accolade Market Cap
Biofrontera has a market cap or net worth of $9.92 million as of August 1, 2025. Its market cap has increased by 69.47% in one year.
Market Cap
9.92M
Enterprise Value
12.90M
1-Year Change
69.47%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since the IPO on October 29, 2021, Biofrontera's market cap has decreased from $35.28M to $9.92M, a decrease of -71.89%. That is a compound annual growth rate of -28.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 9.82M | 16.31% |
| Dec 31, 2024 | 8.45M | 100.93% |
| Dec 29, 2023 | 4.20M | -82.82% |
| Dec 30, 2022 | 24.47M | -80.97% |
| Dec 31, 2021 | 128.63M | 264.59% |
| Oct 29, 2021 | 35.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 681.69B |
| Johnson & Johnson | 400.87B |
| AbbVie | 344.43B |
| AstraZeneca | 232.21B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.93B |
| UnitedHealth Group | 217.62B |
| Novo Nordisk | 213.92B |